ofa semaglutide lawsuit Novo Nordisk is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Ozempic Lawsuit: July 2026 Blindness

Research has shown that melanocortin receptor activation promotes glucose uptake in peripheral tissues and enhances lipid mobilization from adipose stores

This process triggers immune responses to produce antibodies and protect us from sicknesses

Coverage for GLP-1 as a diabetes treatment is required because the drugs are FDA-approved for that indication

Mounjaro and Contraception The effectiveness of birth control pills may be reduced when starting Mounjaro (tirzepatide) or after any increase in your dose

Most insurance plans dont cover FDA-approved GLP-1 weight loss medications unless the individual has a qualifying diagnosis like type 2 diabetes or severe obesity

LC-MS/MS Acquisition and Analysis: Samples were resuspended in 10 l of 0.1% TFA and loaded onto a Dionex RSLC Ultimate 300 (Thermo Scientific), coupled online with an Orbitrap Fusion Lumos (Thermo Scientific)